Rare diseases
Investigational molecules
Locations
Study on Patient Preference for Nivolumab and Relatlimab Administration Methods in Melanoma Patients
ItalyStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
ItalyStudy on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases
ItalyStudy on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients
ItalyStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
ItalyStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
ItalyStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
ItalyStudy on Sibeprenlimab for Patients with IgA Nephropathy
ItalyStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
ItalyStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
ItalyStudy on Ertugliflozin for Children and Teens with Type 2 Diabetes
ItalyStudy of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
